PHAXIAM Therapeutics S.A. Foreign Exchange Loss
PHAXIAM Therapeutics S.A. reported Foreign Exchange Loss of EUR 239.00 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2023-09-26
- 2023-06-30: Foreign Exchange Loss 6 month 239.00K EUR.
- 2022-06-30: Foreign Exchange Loss 6 month 480.00K EUR.
- 2021-06-30: Foreign Exchange Loss 6 month 557.00K EUR.
| Period end | Foreign Exchange Loss 6 month |
|---|---|
| 2023-06-30 | 239.00K EUR 6-K · filed 2023-09-26 |
| 2022-06-30 | 480.00K EUR 6-K · filed 2023-09-26 |
| 2021-06-30 | 557.00K EUR 6-K · filed 2022-09-12 |